News from adventrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 11, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"

 ADVENTRX Pharmaceuticals, Inc. today completed its previously announced corporate name change to "Mast Therapeutics, Inc."  In addition,...

Feb 28, 2013, 17:15 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that, effective March 11, 2013, its corporate name will be "Mast Therapeutics,...

Feb 28, 2013, 16:01 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

Adventrx To Develop ANX-188 For Complications Of Arterial Disease

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced its plans to develop ANX-188 in complications of arterial disease, initially as...

Feb 26, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today reviewed the platform of data and know-how that supports development of ANX-188 in...

Feb 25, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at...

Feb 11, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has initiated dosing in a thorough QT/QTc study (TQT study) of...

Feb 05, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present...

Jan 30, 2013, 07:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has initiated patient recruitment in its pivotal phase 3 clinical...

Jan 04, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Appointment of Chief Financial Officer

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced the appointment of Brandi L. Roberts to Chief Financial Officer and Senior Vice...

Jan 02, 2013, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at...

Dec 19, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX To Initiate Phase 3 Study Of ANX-188

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that ANX-188 drug product for use in the phase 3 clinical study of ANX-188...

Dec 03, 2012, 08:30 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Launch Of New Corporate Website

 ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced the launch of its redesigned and updated corporate website,www.adventrx.com....

Nov 05, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Reports Third Quarter 2012 Financial Results

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today reported financial results for the quarter ended September 30, 2012. "With a strong cash...

Oct 25, 2012, 16:05 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today provided details regarding the phase 3 clinical study of ANX-188 (purified poloxamer 188) in...

Oct 23, 2012, 08:30 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Conference Call To Review Protocol For Phase 3 Clinical Study Of ANX-188

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it will hold a conference call at 4:30 p.m. Eastern Time, 1:30 p.m. Pacific...

Oct 02, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Engages Theradex Systems, Inc. to Manage Phase 3 Clinical Study of ANX-188

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that it has engaged Theradex® Systems, Inc., a contract research organization...

Sep 07, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that Ted W. Love, M.D., has joined its Board of Directors. Dr. Love most recently...

Aug 28, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the...

Aug 14, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Announces Appointment Of Chief Medical Officer

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that Santosh J. Vetticaden, M.D., Ph.D., will join the Company as Chief Medical...

Aug 06, 2012, 08:00 ET
Mast Therapeutics, Inc. logo. (PRNewsFoto/Mast Therapeutics, Inc.)

ADVENTRX Reports Second Quarter 2012 Financial Results

ADVENTRX Pharmaceuticals, Inc. (NYSE MKT: ANX) today reported financial results for the quarter ended June 30, 2012. "We start the second...